NEW YORK (GenomeWeb News) – Illumina said today that it has certified German firm Life & Brain to provide services using its genetic analysis technology.
 
Life & Brain is the first company in Germany to become a certified service provider under Illumina’s CSPro partnership program, the company said.
 
Life & Brain offers whole-genome genotyping services based on Illumina's Infinium assay.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.